# Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients

> **NCT03539757** · — · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 6 (actual)

## Conditions studied

- Liver Fibrosis

## Interventions

- **DEVICE:** Non-Contrast Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT03539757
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-09
- **Primary completion:** 2022-03-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Due to lack of enrollment this study was permanatly closed March 2022. The incidence of FONTAN patients being referred for liver biospsies and occurance of COVID effected participants enrolled.
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03539757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03539757, "Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03539757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*